Becton, Dickinson and Company (BD)
Becton, Dickinson and Company (BD) holds a dominant position in the global prefilled syringes (PFS) market as a top-tier US-based medical technology corporation. Leveraging its extensive manufacturing scale and deep expertise, the company is a world leader in developing, manufacturing, and selling both conventional and safety-engineered PFS products. BD’s strategic focus centers on system integration, safety innovation, and enhancing supply chain visibility. A key product line includes the BD Hypak, BD Neopak, and the BD Sterifill Advance polymer PFS. In an effort to keep up with biopharmaceutical demand, BD introduced the effivax™ glass prefilled syringe to improve reliability and efficiency in vaccine production. The company is actively innovating traceability through solutions like the BD iDFill™ Individual Prefillable Syringe Identification, an RFID-based technology aimed at enhancing fill-and-finish traceability. By continuously investing in its manufacturing capacities and focusing on minimizing drug waste, BD supports the expanding vaccine pipeline and contributes to safer, more efficient drug administration across various global healthcare sectors.
Latest Market Research Report on Prefilled Syringes Download PDF Brochure Now
SCHOTT Pharma (formerly SCHOTT AG)
SCHOTT Pharma, with roots in Germany, maintains a critical and leading position in the prefilled syringes market by specializing in advanced pharmaceutical glass and polymer packaging solutions. The company’s core strategy revolves around material innovation and customization to support highly sensitive drug formulations and demanding storage conditions. Their product portfolio is tailored for modern biopharmaceuticals, including the syriQ BioPure® glass PFS, which features low, uniform silicone levels, and the SCHOTT TOPPAC® polymer syringe line. SCHOTT is a pioneer in solutions compatible with deep-cold temperatures, launching polymer syringes essential for the secure transportation and preservation of temperature-sensitive drugs like certain mRNA vaccines. Furthermore, their offerings extend to specialty products like TOPPAC infuse polymer syringes, aiming to boost safety and efficiency in drug delivery. By providing stable, convenient, and safe storage and delivery systems, SCHOTT AG assists pharmaceutical companies globally in quickly entering markets while maintaining the highest quality and purity standards.
Gerresheimer AG
Gerresheimer AG is a leading German-based partner in the global pharmaceutical and healthcare industries, with a significant footprint in the prefilled syringes market. The company specializes in providing a broad range of high-quality, specialized glass and plastics packaging, alongside drug delivery devices and solutions. Gerresheimer’s expertise in PFS is centered at its Bunde, Germany, facility, which serves as its Center of Excellence for prefillable glass syringes. Their flagship products include the Gx® Prefillable Glass Needle Syringes, which are available in both bulk and “Ready-to-Fill” (RTF®) variations. The Gx RTF technology is a key offering, designed to simplify the filling process for drug manufacturers and reduce drug waste. Gerresheimer also offers polymer options like the Gx RTF® ClearJect® Plastic Syringe. Through continuous innovation, such as recent collaborations to launch complete silicone-oil- and PFAS-free syringe systems, Gerresheimer delivers customizable and high-purity solutions crucial for sensitive biologic and ophthalmic drug formulations.
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. is a globally recognized provider of innovative solutions for injectable drug administration, with a specialized focus on high-quality prefilled syringes and syringe components. The US-based company offers a comprehensive portfolio that includes containment solutions, primary packaging, and drug delivery systems. West’s strategy emphasizes patient safety and ensuring drug integrity, catering to the growing need for delivery systems for delicate medications and smaller, specialized production runs. They are a significant contributor to the global market by offering top-notch systems that strictly adhere to regulatory standards. Key innovations include the OptiFill™ Ready-to-Use (RTU) vials and cartridges, which offer convenience and efficiency to drug manufacturers. Additionally, West markets various safety systems and is known for its collaboration on advanced materials, such as the licensed Daikyo Crystal Zenith components, to meet the sophisticated demands of the biopharmaceutical industry.
Terumo Corporation
Terumo Corporation, a Japanese medical technology company, is a vital player in the prefilled syringes (PFS) market, known for developing high-standard medical devices and specialized PFS solutions. The company focuses on innovative designs that help ensure accurate medication administration and enhanced safety. A notable example is the revolutionary PLAJEX 0.5mL luer lock pre-fillable syringe, which removes silicone oil from the product contact surface, leading to a decrease in particle contamination—a critical factor for sensitive drug stability. Furthermore, Terumo’s I-coating technology guarantees steady performance for high-value drug delivery, specifically addressing commercialization obstacles in complex sectors like the ophthalmic industry. By continuously investing in advanced material science and design, Terumo helps healthcare providers worldwide with durable, high-quality PFS that improve patient care and drug management.
Nipro Corporation
Nipro Corporation is a major Japanese manufacturer of medical equipment, pharmaceuticals, and packaging items, with its Nipro PharmaPackaging International segment driving its prefilled syringe business. The company provides a range of high-quality glass and plastic prefilled syringes globally. One of its key offerings is the AMSafe ® pre-filled normal saline flush syringe, which is designed to enhance patient safety by standardizing the flushing process and streamlining workflow for healthcare professionals. Nipro is also focused on improving the efficiency of the drug manufacturing process itself. The company introduced CURACASE, an individually packaged product contained in a hard-plastic container, which is compatible with automated feeders and pick-and-place systems, thereby optimizing the secondary packaging and assembly of complete injection systems. Nipro’s commitment to new methods and expanded manufacturing capacity solidifies its position as a global supplier supporting safer and more efficient drug delivery.
Stevanato Group
The Stevanato Group, an Italian company, is an integral partner in the pharmaceutical industry, providing end-to-end solutions that place it firmly in the prefilled syringes market. The company is a prominent manufacturer of pharmaceutical glass containers, specializing in high-quality glass tubing and finished primary packaging, including prefilled syringes. Stevanato Group differentiates itself by offering precision and durability, providing advanced glass syringes and integrated injection systems. Their capabilities include advanced equipment and services, supporting the pharmaceutical company across the entire lifecycle, from drug development through to high-speed fill-and-finish processes. The Group’s dedication to quality and advanced manufacturing technology enables them to cater to the complex and specialized drug delivery needs of the global biopharmaceutical market.
Catalent, Inc.
Catalent, Inc. is a leading global Contract Development and Manufacturing Organization (CDMO) that plays a significant role in the prefilled syringes market by providing comprehensive and customized drug delivery technology and solutions. As a trusted partner to pharmaceutical and biotechnology companies, Catalent offers expertise that spans drug development, manufacturing, and packaging. In the PFS space, the company delivers customized prefilled syringe solutions, supporting clients in bringing their injectable drugs to market faster. By leveraging its vast network and regulatory knowledge, Catalent ensures safety, quality, and compliance throughout the product lifecycle. Their service offering is crucial for drug sponsors who seek to minimize product loss and maximize efficiency by outsourcing the complex process of filling, finishing, and packaging high-value biologic and complex small molecule drugs into PFS formats.
AptarGroup Inc.
AptarGroup Inc., through its Aptar Pharma division, is a key global player specializing in drug delivery systems and active packaging solutions, which includes a strong focus on components for prefilled syringes. The company’s role is primarily as a supplier of innovative components that enhance the safety, integrity, and user-friendliness of PFS. Aptar Stelmi, for example, provides critical components like Rigid Needle Shields. Furthermore, Aptar is actively involved in the final delivery aspect of PFS, rapidly increasing its market presence in self-injection devices. A notable product is Click2Pen, an innovative prefilled syringe delivery system designed to simplify the self-administration process for patients, thereby increasing compliance and improving the overall user experience. Aptar’s focus on component science and patient-centric design makes it an essential partner for pharmaceutical companies utilizing prefilled syringe technology.
Latest Market Research Report on Prefilled Syringes Download PDF Brochure Now